Alzinova at Penser by Carnegie’s company day

Last week Alzinova got the opportunity to present at Penser by Carnegie’s company day. CEO Kristina Torfgård talked about Alzinova’s latest progress with the vaccine candidate ALZ-101, as well as future objectives with the main intention to enter into a partnering agreement for the upcoming phase 2 study.